Trending Topic

9 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked
Birjis Fatma, Syed Shoeb Ahmad, Abid Nadeem Nomani

Breast carcinoma is the most common cancer in females. An estimated 2.3 million new cases of breast carcinoma are diagnosed annually worldwide.1 These patients have potential risks of ocular complications not only from the secondaries in the eye but also due to the side effects of medications such as corticosteroids and cytotoxic drugs used to treat […]

Jesse Pelletier – The Role of Povidone-iodine in COVID-19

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Aug 6th 2020

Jesse Pelletier (Ocean Ophthalmology Group, North Miami Beach, FL, USA) discusses the role of the antiseptic povidone-iodine (PVP-I), which is now routinely employed and will play a greater role in the future of healthcare, particularly in the COVID-19 era.

Questions:

1. Tell us about infection control in your office during this pandemic and where povidone-iodine (PVP-I) fits in?
2. What is the rationale behind PVP-I utilization in the nose and mouth?
3. Can you simply dilute “stock” PVP-I and use it?
4. Are these strategies broadly applicable to other specialties across medicine?

Disclosure: Jesse Pelletier is co-founder of Veloce BioPharma and Halodine, LLC.

touchOPHTHALMOLOGY.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via free-to-access content in multimedia formats.

Commissioned, edited and funded by Touch Medical Media
Published: 6 August 2020

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup